BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 27/06/2016

FDA Extends Comment Period for Direct-Acting Antiviral Drug Guidance

The FDA is extending the comment period for a draft guidance on developing direct-acting antiviral drugs for treating chronic hepatitis C virus infection, originally set to close on July 5, 2016, due to maintenance on the Federal eRulemaking portal.

Source: Federal Register — Food and Drug AdministrationOpen original release →